Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities

Lignende værker

• Acute Myeloid Leukemia Following Myelodysplastic Syndrome and Failure of Therapy with Hypomethylating Agents: An Emerging Entity With a Poor Prognosis
  af: Jabbour, Elias, et al.
  Udgivet: (2013)
• The Heterogeneous Prognosis Of Patients With Myelodysplastic Syndrome (MDS) And Chromosome 5 Abnormalities: How Does It Relate To The Original Lenalidomide Experience in MDS?
  af: Kantarjian, Hagop, et al.
  Udgivet: (2009)
• Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications
  af: Ameri, Ali Al, et al.
  Udgivet: (2011)
• Similar outcome of patients with chronic myeloid leukemia treated with imatinib on or off clinical trials
  af: Yilmaz, Musa, et al.
  Udgivet: (2013)
• Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy
  af: Ravandi, Farhad, et al.
  Udgivet: (2010)